New Delhi: The Indian multinational biotechnology company Bharat Biotech on June 3 said “Our Covaxin vaccine is overall 77.8 percent effective against Covid. Bharat Biotech’s final analysis from Phase 3 trial data shows that Covaxin is 65 percent effective against Delta variant.” Bharat Biotech claims they conducted the largest efficacy trial in India with 25,800 […]